Detalles de la búsqueda
1.
Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide.
N Engl J Med
; 383(11): 1040-1049, 2020 09 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32905676
2.
Radium-223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access Program.
Oncologist
; 23(2): 193-202, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29183960
3.
Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial.
Lancet Oncol
; 17(9): 1306-16, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27473888
4.
Chemotherapy following radium-223 dichloride treatment in ALSYMPCA.
Prostate
; 76(10): 905-16, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27004570
5.
A randomized phase II trial of maintenance therapy with Sorafenib in front-line ovarian carcinoma.
Gynecol Oncol
; 130(1): 25-30, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23591401
6.
A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxel.
Clin Cancer Res
; 14(15): 4836-42, 2008 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18676756
7.
Radium-223 in combination with docetaxel in patients with castration-resistant prostate cancer and bone metastases: a phase 1 dose escalation/randomised phase 2a trial.
Eur J Cancer
; 114: 107-116, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31082669
8.
Evaluation of Clinically Relevant Drug-Drug Interactions and Population Pharmacokinetics of Darolutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer: Results of Pre-Specified and Post Hoc Analyses of the Phase III ARAMIS Trial.
Target Oncol
; 14(5): 527-539, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31571095
9.
Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial.
Eur Urol
; 73(3): 427-435, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28705540
10.
Phase I trial of sorafenib and gemcitabine in advanced solid tumors with an expanded cohort in advanced pancreatic cancer.
Clin Cancer Res
; 12(1): 144-51, 2006 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16397036
11.
A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): study protocol for a randomized controlled trial.
Trials
; 14: 228, 2013 Jul 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-23876062
12.
Phase II trial of sorafenib in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or nasopharyngeal carcinoma.
J Clin Oncol
; 25(24): 3766-73, 2007 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-17704426
13.
Phase I and pharmacokinetic study of Bay 38-3441, a camptothecin glycoconjugate, administered as a 30-minute infusion daily for five days every 3 weeks in patients with advanced solid malignancies.
Invest New Drugs
; 23(5): 455-65, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16133797
Resultados
1 -
13
de 13
1
Próxima >
>>